# Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors

> **NCT05952687** · PHASE1 · WITHDRAWN · sponsor: **St. Jude Children's Research Hospital**

## Conditions studied

- Rhabdoid Tumor
- Atypical Teratoid/Rhabdoid Tumor
- Atypical Teratoid/Rhabdoid Tumor of CNS
- CNS Tumor

## Interventions

- **DRUG:** Idasanutlin
- **DRUG:** Idasanutlin
- **DRUG:** Selinexor

## Key facts

- **NCT ID:** NCT05952687
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-03
- **Primary completion:** 2025-09
- **Final completion:** 2032-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Drug withdrawn by company.
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05952687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05952687, "Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05952687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*